Showing 51-60 of 5404 results for "".
- FDA Grants Priority Review to Zasocitinib for Plaque Psoriasishttps://practicaldermatology.com/news/fda-grants-priority-review-to-zasocitinib-for-plaque-psoriasis/2488421/The US Food and Drug Administration (FDA) has accepted Takeda’s new drug application (NDA) for zasocitinib (TAK-279) for adults with moderate-to-severe plaque psoriasis and granted the application Priority Review, according to a company announcement.
- PCA SKIN Launches Acne Control Prebiotic Gel Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-acne-control-prebiotic-gel-cleanser/2488391/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a daily cleanser designed for acne-prone skin that pairs acne-fighting ingredients with technology intended to support the skin microbiome. The gel-to-lather cleanser contains 2% salicylic acid to help clear and prevent acne breako
- DRESS: Tofacitinib Shows Glucocorticoid-Sparing Potentialhttps://practicaldermatology.com/news/dress-tofacitinib-shows-glucocorticoid-sparing-potential/2488346/Adding tofacitinib to systemic glucocorticoid therapy was associated with reduced glucocorticoid exposure and faster clinical improvement among patients with drug reaction with eosinophilia and systemic symptoms (DRESS), according to a study published online in the
- GLP-1 Weight Loss Not Linked to Higher Body-Contouring Surgery Complication Rateshttps://practicaldermatology.com/news/glp-1-weight-loss-not-linked-to-higher-body-contouring-surgery-complication-rates/2488256/The method patients used to lose weight—including injectable glucagon-like peptide-1 (GLP-1) receptor agonist pharmacotherapy—was not associated with differences in postoperative complication rates after body-contouring surgery, according to a retrospective study p
- Global Study Maps Wide Disparities in Access to Dermatologic Carehttps://practicaldermatology.com/news/global-study-maps-wide-disparities-in-access-to-dermatologic-care/2488213/A global analysis of dermatologic care found substantial disparities in dermatologist availability, training opportunities, and access to specialty services, with lower-resource countries facing the greatest gaps. The cross-sectional study surveyed dermatology leaders across World Health O
- GLP-1 Receptor Agonists Not Linked to Increased Melanoma Risk in T2Dhttps://practicaldermatology.com/news/glp-1-receptor-agonists-not-linked-to-increased-melanoma-risk-in-t2d/2488105/GLP-1 receptor agonist (GLP-1RA) therapy was not associated with an increased risk of melanoma among adults with type 2 diabetes (T2D) in a large target trial emulation published in Diabetes, Obesity and Metabolism. GLP-1RA Use and Skin Cancer Risk Investigators used TriN
- GLP-1 Receptor Agonists Linked to Reduced Psoriasis Treatment Escalation in Type 2 Diabetics: Analysishttps://practicaldermatology.com/news/glp-1-receptor-agonists-linked-to-reduced-psoriasis-treatment-escalation-in-type-2-diabetics-analysis/2487939/Adults with psoriasis and type 2 diabetes mellitus (T2DM) treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were less likely to require escalation of psoriasis therapy than patients receiving most other antihyperglycemic medications, according to
- Psychological Burden of Atopic Dermatitis Appears Greatest in Children and Adolescentshttps://practicaldermatology.com/news/psychological-burden-of-atopic-dermatitis-appears-greatest-in-children-and-adolescents/2487888/Children and adolescents with atopic dermatitis (AD) may experience a greater psychological burden than adults with the disease, according to a systematic review and meta-analysis published in Frontiers in Public Health.¹ However, investigators cautioned
- Imaging-Guided Tape Stripping Standardizes Molecular Profiling in Pediatric Atopic Dermatitishttps://practicaldermatology.com/news/imaging-guided-tape-stripping-standardizes-molecular-profiling-in-pediatric-atopic-dermatitis/2487887/A minimally invasive, imaging-guided tape-stripping technique may provide a standardized method for molecular profiling and treatment monitoring in pediatric atopic dermatitis (AD), according to findings published online ahead of print in the
- Guideline-Based Management Limits Testing and Identifies Risk Factors for Chronic Urticaria in Childrenhttps://practicaldermatology.com/news/guideline-based-management-limits-testing-and-identifies-risk-factors-for-chronic-urticaria-in-children/2487889/Most children presenting with a first episode of acute urticaria (AU) recover with conservative, guideline-based management and require little diagnostic testing, according to a prospective cohort study published in Pediatric Allergy, Immunology, and Pulmonolog